Can Imirzalioglu
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria 42
- Endocrinology top 0.5%
- Escherichia coli research studies 10
- Enterobacteriaceae and Cronobacter Research 8
- Pollution top 1%
- Pharmaceutical and Antibiotic Environmental Impacts 12
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 12
-
- Urinary Tract Infections Management 9
-
- Genomics and Phylogenetic Studies 7
-
- Streptococcal Infections and Treatments 6
Can Imirzalioglu
74 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 124
- Molecular Medicine 1.6k
- Endocrinology 815
- Applied Microbiology and Biotechnology 291
- Pollution 635
- Clinical Biochemistry 313
Countries citing papers authored by Can Imirzalioglu
This map shows the geographic impact of Can Imirzalioglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Imirzalioglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Imirzalioglu more than expected).
Fields of papers citing papers by Can Imirzalioglu
This network shows the impact of papers produced by Can Imirzalioglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Imirzalioglu. The network helps show where Can Imirzalioglu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Can Imirzalioglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 12 | |
| 8 | 2021 | 5 | |
| 9 | 2020 | 2 | |
| 10 | 2020 | 14 | |
| 11 | 2019 | 121 | |
| 12 | 2017 | 76 | |
| 13 | 2017 | 49 | |
| 14 | 2016 | 68 | |
| 15 | 2015 | 48 | |
| 16 | 2015 | 24 | |
| 17 | 2013 | 69 | |
| 18 | 2011 | 73 | |
| 19 | 2011 | 50 | |
| 20 | 2011 | 131 |
About Can Imirzalioglu
Can Imirzalioglu is a scholar working on Molecular Medicine, Endocrinology and Applied Microbiology and Biotechnology, having authored 76 papers that have together received 2.8k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (42 papers), Bacterial Identification and Susceptibility Testing (12 papers), Pharmaceutical and Antibiotic Environmental Impacts (12 papers), Escherichia coli research studies (10 papers), Urinary Tract Infections Management (9 papers), Enterobacteriaceae and Cronobacter Research (8 papers), Genomics and Phylogenetic Studies (7 papers) and Streptococcal Infections and Treatments (6 papers). The work is most often cited by research in Molecular Medicine (1.6k citations), Endocrinology (815 citations) and Applied Microbiology and Biotechnology (291 citations). Can Imirzalioglu has collaborated with scholars based in Germany, Tanzania and Egypt. Frequent co-authors include Trinad Chakraborty, Stephen E. Mshana, Linda Falgenhauer, Eugen Domann, Torsten Hain, Moritz Fritzenwanker, Mariam M. Mirambo, Martha F. Mushi, Yancheng Yao and Phillipo L Chalya. Their work appears in journals such as Frontiers in Microbiology, BMC Infectious Diseases, Journal of Clinical Microbiology, International Journal of Antimicrobial Agents and BMC Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.